Opinion statement
Neutropenic enterocolitis is a life-threatening gastrointestinal (GI) complication of chemotherapy most often associated with leukemia or lymphoma. Early recognition and treatment are essential for survival. The management of neutropenic enterocolitis is controversial. Neither prospective nor high-quality retrospective studies concerning medical or surgical therapies are available. Treatment approaches have been derived mostly from small case studies and retrospective reports. Therefore, a uniform management strategy cannot be recommended. The best strategy appears to be an individualized approach to each case given the wide spectrum of presentation. There is general agreement that early management should be conservative and should consist of bowel rest, intravenous fluid administration, total parenteral nutrition, broad-spectrum antibiotics, and normalization of neutrophil counts. Surgical intervention is warranted in the setting of perforation, obstruction, clinical deterioration suggestive of uncontrolled sepsis, and persistent GI bleeding despite correction of cytopenias and coagulopathy.
Similar content being viewed by others
References and Recommended Reading
Alt B, Glass NR, Sollinger H: Neutropenic enterocolitis in adults. Review of the literature and assessment of surgical intervention. Am J Surg 1985, 149:405–408. An excellent review on the surgical management of neutropenic enterocolitis.
Williams N, Scott AD: Neutropenic colitis: a continuing surgical challenge. Br J Surg 1997, 84:1200–1205.
Sloas MM, Flynn PM, Kaste SC, Patrick CC: Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis 1993, 17:484–490.
Katz JA, Wagner ML, Gresik MV, et al.: Typhlitis. An 18-year experience and postmortem review. Cancer 1990, 65:1041–1047.
Urbach DR, Rotstein OD: Typhlitis. Can J Surg 1999, 42:415–419.
Avigan D, Richardson P, Elias A, et al.: Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors. A case series with a review of the literature. Cancer 1998, 83:409–414.
Chakravarty K, Scott DG, McCann BG: Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Br J Rheumatol 1992, 31:351–353.
Gomez L, Martino R, Rolston KV: Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clin Infect Dis 1998, 27:695–699.
Gorschlũter M, Mey U, Strehl J, et al.: Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005, 75:1–13. This is the only systematic review of the literature using MEDLINE. The analysis is excellent and the recommendations provocative.
Wade DS, Nava HR, Douglass HO: Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 1992, 69:17–23. A comprehensive review of the diagnosis and treatment of this disease.
Kouroussis C, Samonis G, Androulakis N, et al.: Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol 2000, 23:309–313.
Kirkpatrick ID, Greenberg HM: Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 2003, 226:668–674.
Cartoni C, Dragoni F, Micozzi A, et al.: Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 2001, 19:756–761.
Gorschlüter M, Marklein G, Höfling K, et al.: Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 2002, 117:351–358.
Hughes WT, Armstrong D, Bodey GP, et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730–751.
Solomkin JS, Mazuski JE, Baron EJ, et al.: Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003, 37:997–1005.
Barie PS, Vogel SB, Dellinger EP, et al.: A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg 1997, 132:1294–1302.
Ozer H, Armitage JO, Bennett CL, et al.: 2000 update of recommendations for the use of hematopoietic colonystimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000, 18:3558–3585.
Ikard RW: Neutropenic typhlitis in adults. Arch Surg 1981, 116:943–945.
Varki AP, Armitage JO, Feagler JR: Typhlitis in acute leukemia: successful treatment by early surgical intervention. Cancer 1979, 43:695–697.
Kunkel JM, Rosenthal D: Management of the ileocecal syndrome. Neutropenic enterocolitis. Dis Colon Rectum 1986, 29:196–199.
Weinberger M, Hollingsworth H, Feuerstein IM, et al.: Successful surgical management of neutropenic enterocolitis in two patients with severe aplastic anemia. Case reports and review of the literature. Arch Intern Med 1993, 153:107–113.
Shamberger RC, Weinstein HJ, Delorey MJ, et al.: The medical and surgical management of typhlitis in children with acute non-lymphocytic (myelogenous) leukemia. Cancer 1986, 57:603–609. An excellent paper discussing medical and surgical management of neutropenic enterocolitis.
Koea JB, Shaw JH: Surgical management of neutropenic enterocolitis. Br J Surg 1989, 76:821–824.
Moir CR, Scudamore CH, Benny WB: Typhlitis: selective surgical management. Am J Surg 1986, 151:563–566.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davila, M.L. Neutropenic enterocolitis. Curr Treat Options Gastro 9, 249–255 (2006). https://doi.org/10.1007/s11938-006-0043-2
Issue Date:
DOI: https://doi.org/10.1007/s11938-006-0043-2